BioLineRx (BLRX) Posts Q3 Loss of 1c/ADS

BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.16 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Micron Technology (MU) PT Raised to $1,550 at Needham
• Seacoast Banking (SBCF) PT Raised to $34 at Piper Sandler